5 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18108961 | PROTEINS BINDING NKG2D, CD16 AND NECTIN4 | BRISTOL, LYNN ANNE | 1643 | Final Rejection | Feb 13, 2023 |
| 18166769 | PHARMACEUTICAL FORMULATIONS AND THERAPEUTIC USES OF MULTI-SPECIFIC BINDING PROTEINS THAT BIND EGFR, NKG2D, AND CD16 | CHASE, CAROL ANN | 1646 | Non-Final OA | Feb 09, 2023 |
| 17769160 | PROTEINS BINDING NKG2D, CD16 AND FLT3 | GUSTILO, ESTELLA M | 1646 | Final Rejection | Apr 14, 2022 |
| 17058335 | MULTI-SPECIFIC BINDING PROTEINS AND IMPROVEMENTS THEREON | YAO, LEI | 1642 | Final Rejection | Nov 24, 2020 |
| 16615261 | PROTEINS BINDING NKG2D, CD16 AND A TUMOR-ASSOCIATED ANTIGEN | JOHANSEN, PETER N. | 1644 | Non-Final OA | Nov 20, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial